Theravance Biopharma Inc
- TBPH
- NASDAQ
- Biotechnology
- Respiratory Drugs (COPD)
- Biopharma
$17.03
Quote Sep 23, 2026, 08:00 PM UTC
0.00%over the last month
Max drawdown −0.4%From 1-month high −0.3%3 months −3.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$884.2M
Quote Sep 23
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$17.00
−0.2% from here
Floor
$16.93
0.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TBPHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
90
Founded
2013